Anemia: all 1,768 studies

Page 6 of 18. Open to participants first (244), then studies with results posted, then the rest; newest registration first within each.

• LEARN-6™: A Prospective, Observational Nursing Home StudyCompletedNCT00727571Results posted
• Study to Determine Optimum Intravenous Starting Dose of MIRCERA for Treatment of Pediatric Participants With Anemia and Chronic Kidney Disease on HemodialysisCompletedNCT00717366Phase 2Results posted
• Study to Assess the Efficacy and Safety of HX575 in the Treatment of Chemotherapy Associated Anemia in Cancer PatientsCompletedNCT00711958Phase 3Results posted
• Safety and Tolerability of a Single Dose of FCM vs. Standard of Care in Treating Iron Deficiency AnemiaCompletedNCT00704353Phase 3Results posted
• Safety and Tolerability of Ferric Carboxymaltose (FCM) Versus Iron Dextran in Treating Iron Deficiency AnemiaCompletedNCT00704028Phase 3Results posted
• Safety and Tolerability of Ferric Carboxymaltose (FCM) Versus Standard of Care in Treating Iron Deficiency AnemiaCompletedNCT00703937Phase 3Results posted
• Randomized, Controlled, Double-blind Multicenter Safety Study to Evaluate the Safety and Immunogenicity of Subcutaneous EPO HEXAL vs. ERYPO® in the Treatment of Anemia Associated With Chronic Renal Insufficiency in Predialysis PatientsTerminatedNCT00701714Phase 3Results posted
• A Study of Monthly Intravenous C.E.R.A. (Mircera) in Hemodialysis Participants With Chronic Renal AnemiaCompletedNCT00699348Phase 3Results posted
• Safety & Efficacy of Peginesatide for Treatment of Anemia in Participants on Dialysis Not Receiving an ESACompletedNCT00680043Phase 2Results posted
• Study to Evaluate the Efficacy and Safety of HX575 Hexal AG vs ERYPO® for the Treatment of Anemia in Hemodialysis PatientsCompletedNCT00666835Phase 3Results posted
• TBTC Study 30: Safety and Tolerability of Low Dose Linezolid in MDR TBCompletedNCT00664313Phase 1/2Results posted
• Darbepoetin Alfa With or Without Iron in Treating Anemia Caused By Chemotherapy in Patients With CancerCompletedNCT00661999Phase 3Results posted
• A Study of Intravenous Mircera in Hemodialysis Patients With Chronic Renal AnemiaCompletedNCT00661505Phase 3Results posted
• A Study of Monthly Subcutaneous Mircera for the Treatment of Chronic Renal Anemia in Predialysis Patients Not Treated With ESA.CompletedNCT00661388Phase 3Results posted
• A Study of Intravenous Mircera in Participants With Chronic Renal Anemia Who Are on DialysisCompletedNCT00660023Phase 3Results posted
• STABIL Study: National Study With Mircera for Maintenance of Hemoglobin Level in Dialysis PatientsCompletedNCT00642850Phase 3Results posted
• A Study of Subcutaneous Mircera for the Maintenance Treatment of Participants With Chronic Renal AnemiaCompletedNCT00642668Phase 4Results posted
• A Study of Subcutaneous C.E.R.A. for the Maintenance of Hemoglobin Levels in Participants With Chronic Renal Anemia Not on Dialysis.CompletedNCT00642304Phase 3Results posted
• Efficacy and Safety of Deferasirox in Patients With Chronic Anemia and Transfusional HemosiderosisCompletedNCT00631163Phase 2Results posted
• Cytoxan, Fludara, and Antithymocyte Globulin Conditioning Followed By Stem Cell Transplant in Treating Fanconi AnemiaCompletedNCT00630253Phase 1/2Results posted
• A Study Comparing Subcutaneous Mircera and Darbepoetin Alfa for Maintenance Treatment of Anemia in Kidney Transplant Recipients.CompletedNCT00605345Phase 3Results posted
• A Study of Intravenous Mircera (C.E.R.A or Methoxy Polyethylene Glycol-epoetin Beta) for the Maintenance Treatment of Hemodialysis Participants With Chronic Renal AnemiaCompletedNCT00605293Phase 3Results posted
• Stem Cell Transplant Using Peripheral and Cord Blood Stem Cells to Treat Severe Aplastic Anemia and Myelodysplastic SyndromeCompletedNCT00604201Phase 2Results posted
• Safety and Efficacy of Peginesatide for the Treatment of Anemia in Participants With Chronic Renal Failure Not on DialysisCompletedNCT00598442Phase 3Results posted
• Safety & Efficacy of Peginesatide for the Treatment of Anemia in Participants With Chronic Renal Failure Not on DialysisCompletedNCT00598273Phase 3Results posted
• Safety & Efficacy of Peginesatide for Maintenance Treatment of Anemia in Participants With Chronic Kidney Disease on HemodialysisCompletedNCT00597753Phase 3Results posted
• Safety & Efficacy of Peginesatide for Maintenance Treatment of Anemia in Participants With Chronic Kidney Disease on HemodialysisCompletedNCT00597584Phase 3Results posted
• Hematopoietic Stem Cell Transplantation for Treatment of Patients With Fanconi Anemia Lacking a Genotypically Identical Donor, Using Total Body Irradiation, Cyclophosphamide and FludarabineCompletedNCT00595127Not applicableResults posted
• Antibody Conditioning Regimen For Allogeneic Donor Stem Cell Transplantation Of Patients With Fanconi AnemiaTerminatedNCT00590460Phase 1/2Results posted
• Iodine I 131 Monoclonal Antibody BC8, Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation and Donor Bone Marrow Transplant in Treating Patients With Advanced Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or High-Risk Myelodysplastic SyndromeTerminatedNCT00589316Phase 1Results posted
• Phase 2 Study of PEG-Intron in Hereditary Hemorrhagic TelangiectasiaTerminatedNCT00588146Phase 2Results posted
• L-Glutamine Therapy for Sickle Cell AnemiaTerminatedNCT00586209Phase 2Results posted
• Allogeneic Stem Cell Transplant for Patients With Severe Aplastic AnemiaTerminatedNCT00578903Phase 2Results posted
• A Study of Subcutaneous C.E.R.A. for the Treatment of Anemia in Pre-Dialysis Patients.CompletedNCT00576628Phase 3Results posted
• A Study of Intravenous Mircera in Dialysis Patients With Chronic Renal Disease and Anemia.CompletedNCT00576303Phase 3Results posted
• A Study of Subcutaneous Mircera for the Maintenance Treatment of Dialysis Patients With Chronic Renal Anemia.CompletedNCT00560404Phase 3Results posted
• A Study of Subcutaneous Mircera in Participants With Chronic Kidney Disease Not Treated With ESA or on DialysisCompletedNCT00559637Phase 3Results posted
• A Study of Subcutaneous Mircera Once Monthly in the Treatment of Anemia in Participants With Chronic Kidney Disease Not on DialysisCompletedNCT00559273Phase 3Results posted
• A Study of Mircera for the Maintenance Treatment of Participants With Chronic Renal AnemiaCompletedNCT00550680Phase 3Results posted
• Safety of FCM vs. Standard of Care in Treating Iron Deficiency Anemia in Heavy Uterine Bleeding and Post Partum PatientsCompletedNCT00548860Phase 3Results posted
• Safety and Tolerability of FCM vs Standard of Care in Treating Iron Deficiency Anemia in Chronic Kidney Disease PatientsCompletedNCT00548691Phase 3Results posted
• A Study of Intravenous Mircera for the Correction of Anemia in Dialysis Patients.CompletedNCT00546481Phase 3Results posted
• MIRACLE Study: A Study of Once-Monthly Intravenous Mircera in Hemodialysis Participants With Chronic Renal AnemiaCompletedNCT00545571Phase 3Results posted
• Efficacy, Safety and Tolerability Study of Subcutaneous C.E.R.A. in Pre-Dialysis Participants With Chronic Renal AnemiaTerminatedNCT00517881Phase 3Results posted
• LATINO Study: A Study of Mircera for the Maintenance Treatment of Dialysis Patients With Chronic Renal Anemia.CompletedNCT00517413Phase 3Results posted
• Dynepo Long-Term Safety StudyTerminatedNCT00514813Phase 4Results posted
• Effectiveness of Arginine as a Treatment for Sickle Cell AnemiaCompletedNCT00513617Phase 2Results posted
• Prevalence and Treatment of Anemia in Rehabilitation PatientsTerminatedNCT00511901Phase 4Results posted
• Mobilization and Collection of Peripheral Blood Stem Cells in Patients With Fanconi Anemia Using G-CSF and AMD3100CompletedNCT00479115Phase 1/2Results posted
• Chloroquine and Post Malaria Anaemia StudyCompletedNCT00473837Not applicableResults posted
• MS-275 and GM-CSF in Treating Patients With Myelodysplastic Syndrome and/or Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphocytic LeukemiaCompletedNCT00462605Phase 2Results posted
• A Study of Subcutaneous Mircera for the Treatment of Anemia in Pre-Dialysis Participants With Chronic Kidney Disease.TerminatedNCT00462384Phase 3Results posted
• Stem Cell Transplant (SCT) for Dyskeratosis Congenita or SAACompletedNCT00455312Phase 2/3Results posted
• Extension Study to Evaluate Safety and Tolerability of Peginesatide for Long-Term Treatment of Anemia in Participants With CKD (EU)TerminatedNCT00453973Phase 2Results posted
• Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation Followed by Donor Bone Marrow Transplant, Mycophenolate Mofetil, and Cyclosporine in Treating Patients With Fanconi AnemiaCompletedNCT00453388Phase 2Results posted
• Dynepo Infrequent Dosing StudyTerminatedNCT00450333Phase 3Results posted
• Efficacy of Enteral Iron Supplementation in Critical IllnessCompletedNCT00450177Phase 2Results posted
• A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.TerminatedNCT00442416Phase 3Results posted
• An Efficacy and Safety Study of Epoetin Alfa for Initiation and Maintenance Treatment of Patients With Anemia Associated With Chronic Kidney DiseaseCompletedNCT00440557Phase 3Results posted
• PROCRIT Extended Dosing For Maintenance of Hemoglobin in Pre-Dialysis CKD PatientsCompletedNCT00440466Phase 3Results posted
• Study to Assess Darbepoetin Alfa Dosing for the Correction of Anemia in Pediatric Patients With Chronic Kidney DiseaseTerminatedNCT00436748Phase 3Results posted
• Peginesatide for Maintenance Treatment of Anemia in Participants on HemodialysisCompletedNCT00434330Phase 2Results posted
• A Study of Cinacalcet to Improve Achievement of National Kidney Foundation Kidney Disease Outcomes Quality Initiative (K/DOQI) Targets in Patients With End Stage Renal Disease (ESRD)CompletedNCT00431496Phase 4Results posted
• Purine Analog-Based Conditioning in Patients With Severe Aplastic AnemiaCompletedNCT00427336Not applicableResults posted
• A Study Comparing Mircera and Epoetin Alfa for the Treatment of Anemia in Dialysis Patients With Chronic Kidney Disease.TerminatedNCT00422513Phase 3Results posted
• Epoetin Alfa or Darbepoetin Alfa in Treating Patients With Anemia Caused by ChemotherapyCompletedNCT00416624Phase 2Results posted
• A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients.CompletedNCT00413894Phase 3Results posted
• Darbepoetin Alfa With or Without Intravenous (IV) IronCompletedNCT00401544Phase 2Results posted
• Epoetin Alfa in Treating Anemia in Patients Undergoing Chemotherapy for Multiple MyelomaCompletedNCT00400686Not applicableResults posted
• Fludarabine Phosphate and Total Body Irradiation Followed by a Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndromes or Myeloproliferative DisordersCompletedNCT00397813Phase 2Results posted
• Comparison of the Safety and Efficacy of Intravenous Iron Versus Oral Iron in Subjects Who Display Postpartum AnemiaCompletedNCT00396292Phase 3Results posted
• Comparison of the Safety and Efficacy of Intravenous Iron Versus Oral Iron in the Treatment of Anemia Secondary to Heavy Uterine BleedingCompletedNCT00395993Phase 3Results posted
• A Study of Mircera for the Maintenance Treatment of Anemia in Dialysis PatientsCompletedNCT00394953Phase 3Results posted
• A Study Comparing Two Different PROCRIT Doses to a Dose of ARANESP in Anemic Cancer Patients Receiving ChemotherapyTerminatedNCT00386152Phase 2Results posted
• Extension Study to Evaluate Safety and Tolerability of Peginesatide for Long-Term Treatment of Anemia in Participants With CKDTerminatedNCT00372489Phase 2Results posted
• STIMULATE Study: Anemia Correction and Health-related Quality of Life (HRQoL) Outcomes in Elderly Chronic Kidney Disease (CKD) PatientsTerminatedNCT00364845Phase 3Results posted
• A Study of Subcutaneous (sc) Mircera in Dialysis Patients With Chronic Renal Anemia.CompletedNCT00364832Phase 2Results posted
• RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure TrialCompletedNCT00358215Phase 3Results posted
• Safety and Efficacy of a Hematinic Agent in the Treatment of Postpartum PatientsCompletedNCT00354484Phase 3Results posted
• (ACORD Study) - A Study of NeoRecormon (Epoetin Beta) in Patients With Early Diabetic NephropathyCompletedNCT00354341Phase 3Results posted
• TBI Dose De-escalation for Fanconi AnemiaCompletedNCT00352976Phase 2/3Results posted
• Cyclophosphamide and Anti-thymocyte Globulin Followed By Methotrexate and Cyclosporine in Preventing Chronic Graft-Versus-Host Disease in Patients With Severe Aplastic Anemia Undergoing Donor Bone Marrow TransplantCompletedNCT00343785Phase 2Results posted
• A Study of the Use of PROCRIT (Epoetin Alfa) for the Treatment of Anemia in People With Chronic Kidney Disease Who Live in Long-term Care Facilities.CompletedNCT00337935Phase 2Results posted
• Fludarabine-based Conditioning for Severe Aplastic Anemia (BMT CTN 0301)CompletedNCT00326417Phase 1/2Results posted
• A Study of Treatment With NeoRecormon (Epoetin Beta) in Patients With Chronic Renal AnemiaCompletedNCT00321919Phase 3Results posted
• Heme Iron Polypeptide for Iron Deficiency Anemia in Chronic Renal FailureCompletedNCT00318812Phase 2/3Results posted
• VIT45 Versus Oral Iron in the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney DiseaseCompletedNCT00317239Phase 3Results posted
• Long Term Safety Study of (VIT45) Extension Study: Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney DiseaseCompletedNCT00317226Phase 3Results posted
• Efficacy and Safety of Peginesatide (AF37702) in the Treatment of Anemia in Participants With Chronic Kidney DiseaseCompletedNCT00314795Phase 2Results posted
• Effects of Erythropoietin on Cerebral Vascular Dysfunction and Anemia in Traumatic Brain InjuryCompletedNCT00313716Phase 2/3Results posted
• Myeloablative Umbilical Cord Blood Transplantation in Hematological DiseasesCompletedNCT00309842Phase 2Results posted
• Extension Study of Iron Chelation Therapy With Deferasirox in β-thalassemia and Rare Chronic Anemia PatientsCompletedNCT00303329Phase 2Results posted
• Anemia in Heart Failure With a Preserved Ejection Fraction (HFPEF)CompletedNCT00286182Phase 2Results posted
• Three Immunosuppressive Treatment Regimens for Severe Aplastic AnemiaCompletedNCT00260689Phase 2Results posted
• Epoetin Alfa in Treating Patients With Anemia Who Are Undergoing Chemotherapy for CancerTerminatedNCT00258440Not applicableResults posted
• Hematopoietic Stem Cell Transplantation in High Risk Patients With Fanconi AnemiaCompletedNCT00258427Phase 2Results posted
• Partially Matched Stem Cell Transplantation for Patients With Refractory Severe Aplastic Anemia or Refractory CytopeniasCompletedNCT00244010Not applicableResults posted
• Comparison of Safety and Efficacy of Intravenous Iron Versus Oral Iron in Chronic Renal Failure Subjects With AnemiaCompletedNCT00236977Phase 3Results posted
• Intravenous (IV) Iron vs. No Iron as the Treatment of Anemia in Cancer Patients Undergoing Chemotherapy and Erythropoietin TherapyCompletedNCT00236951Phase 3Results posted
• Efficacy and Safety of Venofer (Iron Sucrose Injection USP) in Patients Receiving Peritoneal DialysisCompletedNCT00236938Phase 3Results posted

← Anemia overview